A pathogenic role for inflammatory cytokines in neurodegeneration is supported by the increased risk for AD in people with rheumatoid arthritis (RA), psoriasis, and other inflammatory diseases, and a significantly reduced incidence of AD for those patients that received treatment with TNF blocking agents (Zhou et al., 2020). Here, TNF is linked to Alzheimer disease.